Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
100Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $480.14M | $19.52M | $1.08 |
| 2024 | $454.36M | $7.70M | $0.41 |
| 2023 | $445.32M | $15.08M | $0.79 |
| 2022 | $421.91M | $-390.0K | $-0.02 |
| 2021 | $444.08M | $28.85M | $1.45 |
Social Signal Score
Earnings
Thu, Nov 5(in 3 months)
Consensus estimate $0.27 per share
Typical surprise +47.1% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 6$0.21 vs $0.27miss
- Thu, May 7$0.30 vs $0.20beat
- Tue, Mar 10$0.30 vs $0.18beat
- Thu, Nov 6$0.36 vs $0.19beat
- Thu, Jul 31$0.35 vs $0.18beat
- Tue, May 6$0.25 vs $0.17beat
Estimates and results for NATR via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from NATR's reported EPS growth of -7.1% a year over 4 years.
- EPS in 5 years
- $0.75
- Implied price
- $15.00
- Return from $15.12
- -0.2% a year
To earn 15.0% a year on these assumptions you'd need to buy at $7.46 — -50.7% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 14 | 17 | 20 | 23 | 26 |
|---|---|---|---|---|---|
| -17.1% | -17.0% | -13.8% | -10.9% | -8.4% | -6.1% |
| -12.1% | -12.0% | -8.5% | -5.5% | -2.8% | -0.4% |
| -7.1% | -7.0% | -3.3% | -0.2% | 2.7% | 5.2% |
| -2.1% | -2.0% | 1.9% | 5.2% | 8.2% | 10.9% |
| 2.9% | 3.0% | 7.1% | 10.6% | 13.7% | 16.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (1)
- Newsmarketbeat.com·5h ago·Neutral
Nature's Sunshine Targets $1B Sales, 15% EBITDA Margin in Growth Push Nature's Sunshine Products NASDAQ: NATR outlined a strategy to double sales to $1 billion and expand EBITDA margins to 15%, with Chief Executive Officer Ken Romanzi pointing to geographic expansion, digital and retail channel development, marketing initiatives and acquisitions as the company's primary growth drivers.
View source ↗